Frank A.E. Kruyt

10.0k citations

140 papers · 7.9k indexed · 1 hit paper · h-index 50

Molecular Biology top 1%
Oncology top 1%
Cancer Research top 0.5%
Immunology top 5%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Giuseppe Giaccone Linda E. Bröker José Antonio Rodríguez Simone W. Span Carlos Gil Ferreira Godefridus J. Peters Justin V. Joseph Maarten L. Janmaat
Topics: Cell death mechanisms and regulation (45 papers)DNA Repair Mechanisms (21 papers)Cancer-related Molecular Pathways (20 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Advanced Materials
Partner nations: Netherlands United States Japan

In The Last Decade

Frank A.E. Kruyt

137 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell Death Independent of Caspases: A Review

2005 738 citations Frank A.E. Kruyt, Giuseppe Giaccone et al. profile →

Peers

Countries citing papers authored by Frank A.E. Kruyt

Since Specialization

Citations

This map shows the geographic impact of Frank A.E. Kruyt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank A.E. Kruyt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank A.E. Kruyt more than expected).

Fields of papers citing papers by Frank A.E. Kruyt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank A.E. Kruyt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank A.E. Kruyt. The network helps show where Frank A.E. Kruyt may publish in the future.

Co-authorship network of co-authors of Frank A.E. Kruyt

This figure shows the co-authorship network connecting the top 25 collaborators of Frank A.E. Kruyt. A scholar is included among the top collaborators of Frank A.E. Kruyt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank A.E. Kruyt. Frank A.E. Kruyt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HSP90 inhibition reverses resistance to TRAIL-induced apoptosis in non-small cell lung cancer cells 2025 ·SHILAP Revista de lepidopterología ·Kaamar Azijli,Geng Xu,(unknown),(unknown),Shiv Pillai,Sjors M. Kas,Antonio Russo,Elisa Giovannetti,Steven de Jong,Godefridus J. Peters,Frank A.E. Kruyt	0
2	Bioinspired Processing: Complex Coacervates as Versatile Inks for 3D Bioprinting 2023 ·Advanced Materials ·(unknown),(unknown),(unknown),Armin Amirsadeghi,Peter Dijkstra,Daniele Parisi,Frank A.E. Kruyt,Patrick van Rijn,Małgorzata K. Włodarczyk‐Biegun,Marleen Kamperman	32
3	TMIC-80. PERK CONTRIBUTES TO GLIOBLASTOMA PROGRESSION BY REGULATING GLIOBLASTOMA STEM CELL ADAPTATION TO EXTRA CELLULAR MATRIX STIFFENING THROUGH F-ACTIN REMODELING AND FOCAL ADHESION COMPLEX REGULATION 2023 ·Neuro-Oncology ·(unknown),Liang Dong,(unknown),(unknown),Marleen Kamperman,Patrick van Rijn,Frank A.E. Kruyt	0
4	Evaluation of Ac-Lys0(IRDye800CW)Tyr3-octreotate as a novel tracer for SSTR2-targeted molecular fluorescence guided surgery in meningioma 2021 ·Journal of Neuro-Oncology ·(unknown),Marion de Jong,(unknown),Fritz Andreae,(unknown),Marieke Everts,Schelto Kruijff,Julie Nonnekens,Wilfred F.A. den Dunnen,Frank A.E. Kruyt,Rob J. M. Groen	7
5	Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses 2016 ·Journal of Neuro-Oncology ·Siobhan Conroy,Michiel Wagemakers,Annemiek Walenkamp,Frank A.E. Kruyt,Wilfred F.A. den Dunnen	17
6	GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma 2014 ·Digestive and Liver Disease ·K. V. Pavlov,(unknown),Coby Meijer,Wytske Boersma‐van Ek,Frans Peters,Anke van den Berg,Arend Karrenbeld,John Th. M. Plukker,Frank A.E. Kruyt,Jan H. Kleibeuker	10
7	Two death-inducing human TRAIL receptors to target in cancer: Similar or distinct regulation and function? 2014 ·Biochemical Pharmacology ·(unknown),Wim J. Quax,Frank A.E. Kruyt	55
8	TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion 2014 ·Cell Death and Disease ·Justin V. Joseph,Simon Conroy,Tushar Tomar,Ellie Eggens‐Meijer,Krishna Bhat,Sjef Copray,Annemiek Walenkamp,Erik Boddeke,(unknown),Michiel Wagemakers,Wilfred F.A. den Dunnen,Frank A.E. Kruyt	139
9	Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3 dependent invasion in resistant non-small cell lung cancer cells 2012 ·Journal of Cell Science ·Kaamar Azijli,Saravanan Yuvaraj,Maikel P. Peppelenbosch,Thomas Würdinger,Henk Dekker,Jos Joore,(unknown),Wim J. Quax,Godefridus J. Peters,Steven de Jong,Frank A.E. Kruyt	59
10	TGF-β as a therapeutic target in high grade gliomas – Promises and challenges 2012 ·Biochemical Pharmacology ·Justin V. Joseph,Veerakumar Balasubramaniyan,Annemiek Walenkamp,Frank A.E. Kruyt	134
11	Bortezomib and TRAIL: A perfect match for apoptotic elimination of tumour cells? 2012 ·Critical Reviews in Oncology/Hematology ·(unknown),Jan Kroon,Gerrit Jansen,Steven de Jong,Godefridus J. Peters,Frank A.E. Kruyt	63
12	TUCAN/CARDINAL/CARD8 and apoptosis resistance in non-small cell lung cancer cells 2006 ·BMC Cancer ·Agnieszka Chęcińska,Giuseppe Giaccone,(unknown),Carlos Gil Ferreira,José Antonio Rodríguez,Frank A.E. Kruyt	12
13	Expression and localization of inhibitor of apoptosis proteins in normal human tissues 2005 ·Human Pathology ·Barbara Vischioni,Paul van der Valk,Simone W. Span,Frank A.E. Kruyt,José Antonio Rodríguez,Giuseppe Giaccone	62
14	FANCD2 Expression in Advanced Non–Small-Cell Lung Cancer and Response to Platinum-Based Chemotherapy 2005 ·Clinical Lung Cancer ·Miriam Ferrer,Simone W. Span,Barbara Vischioni,Joost J. Oudejans,P. J. van Diest,Johan P. de Winter,Giuseppe Giaccone,Frank A.E. Kruyt	14
15	Nuclear shuttling and TRAF2-mediated retention in the cytoplasm regulate the subcellular localization of cIAP1 and cIAP2 2004 ·Experimental Cell Research ·Barbara Vischioni,Giuseppe Giaccone,Simone W. Span,Frank A.E. Kruyt,José Antonio Rodríguez	36
16	Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity 2003 ·British Journal of Cancer ·Michiel de Bruin,(unknown),Kasper van der Born,Frank A.E. Kruyt,Masakazu Fukushima,Klaas Hoekman,Herbert M. Pinedo,Godefridus J. Peters	62
17	Resistance to Mitomycin C Requires Direct Interaction between the Fanconi Anemia Proteins FANCA and FANCG in the Nucleus through an Arginine-rich Domain 1999 ·Journal of Biological Chemistry ·Frank A.E. Kruyt,(unknown),Henry Mok,Hagop Youssoufian	49
18	Regulated binding of the Fanconi anemia proteins, FANCA and FANCC - Response 1999 ·Blood ·Frank A.E. Kruyt,Hagop Youssoufian	1
19	Normal expression of the Fanconi anemia proteins FAA and FAC and sensitivity to mitomycin C in two Patients with Seckel syndrome 1999 ·American Journal of Medical Genetics ·(unknown),Bassem A. Bejjani,Frank A.E. Kruyt,Reet Kurg,Carlos A. Bacino,Stuart K. Shapira,Hagop Youssoufian	10
20	Retinoic acid resistance of the variant embryonal carcinoma cell line RAC65 is caused by expression of a truncated RARα 1992 ·Differentiation ·Frank A.E. Kruyt,(unknown),(unknown),C.E. van den Brink,A. Feijen,Luigi J.C. Jonk,W. Kruijer,Paul T. van der Saag	40

About Frank A.E. Kruyt

Frank A.E. Kruyt is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 140 papers that have together received 7.9k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (45 papers), DNA Repair Mechanisms (21 papers) and Cancer-related Molecular Pathways (20 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (2.3k citations) and Molecular Biology (5.7k citations). Frank A.E. Kruyt has collaborated with scholars based in Netherlands, United States and Japan. Frequent co-authors include Giuseppe Giaccone, Linda E. Bröker, José Antonio Rodríguez, Simone W. Span, Carlos Gil Ferreira, Godefridus J. Peters, Justin V. Joseph, Maarten L. Janmaat, Steven de Jong and Hagop Youssoufian. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Advanced Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact